SCHEMBL3756709

SCHEMBL3756709

CCOC(=O)c1cccc(-c2cc(-c3c(N4CCOCC4)sc4c3CC(C)(C)CC4=O)ccn2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.47
JMJD6 Q6NYC1 2/20 0.46
PRKDC P78527 1/20 0.44
RXFP1 Q9HBX9 1/20 0.42
POLB P06746 1/20 0.39
ALDH1A1 P00352 5/20 0.38
GAA P10253 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3R2 O00459 1/20 0.38
BRD4 O60885 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.37
SIRT1 Q96EB6 1/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3760325 0.94 PRKDC (0.49) PIK3CAJMJD6PRKDCRXFP1POLB
SCHEMBL3762759 0.90 PRKDC (0.40) PIK3CAJMJD6PRKDCPOLBALDH1A1
SCHEMBL3761577 0.90 PRKDC (0.42) PIK3CAJMJD6PRKDCALDH1A1PIK3CD
SCHEMBL3760897 0.90 STK4 (0.43) PIK3CAJMJD6PRKDCALDH1A1PIK3CD
SCHEMBL3767645 0.89 ALDH1A1 (0.38) PIK3CAJMJD6PRKDCALDH1A1PIK3CD
SCHEMBL3762158 0.89 LRRK2 (0.38) PIK3CAALDH1A1PIK3CDBRD4PIK3CB
SCHEMBL3761442 0.89 MTOR (0.38) PIK3CAJMJD6PRKDCALDH1A1PIK3CD
SCHEMBL3764901 0.88 PIK3CA (0.41) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL3762316 0.88 LRRK2 (0.41) PIK3CAJMJD6ALDH1A1PIK3CDPIK3CB
SCHEMBL3760222 0.88 PIK3CA (0.45) PIK3CAPRKDCPIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CA 3/4885JMJD6 3134/4885PRKDC 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.